This is another good question for the CC if Joe does not address it. However, it appears that he does plan to address it, at least by the end of October.

"The conversation then turned to the Company's spin-out of Antigen Express, Inc. d/b/a NuGenerex Immuno-Oncology. "The spin-out is planned," explained Moscato, adding that the Company is currently undergoing the proper legal and financial work required to finalize this process. "We've given a dividend to our shareholders in that company, and that should become a reality by the end of October."